In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
Dr Frank Wuest, Professor at Department of Oncology - University of Alberta, sheds light on the imaging biomarkers and the Alberta Radiopharmaceutical Collaboration in this special oncology focus.
Doctor Allon Barsam, consultant eye surgeon and founder of Ophthalmic Consultants of London, calls attention to the unexplored devastation behind the NHS virus frontlines.
Mark Daly, Director of the Institute for Molecular Medicine Finland (FIMM), HiLIFE at the University of Helsinki, shares his expertise on medical genetic research on a population scale in Finland.
Here, the International Agency for Research on Cancer and other experts provide an in-depth analysis of cancer, the second leading cause of death after cardiovascular diseases plus the role of technology and innovation in the field.
Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.
Monique van Leerdam, leading colorectal cancer expert and Member of the United European Gastroenterology Public Affairs Committee, discusses what action can be taken to reduce the heavy burden of colorectal cancer across Europe.
Peter Goodhand and Angela Page from Global Alliance for Genomics and Health, explain their thoughts on enabling a global learning health system through genomic standards.
In the current moment, how severely is the viral misinformation online (from anti-vaccination movements to deadly 'miracle' cures) impacting the medical industry?
The Global Food Research Program shares their perspective on targeting ultra-processed foods with front-of-the-package warning labels, which is the only impactful approach.
The National Cancer Research Institute (NCRI) released figures today (4 February) showing that NCRI funding has reached £700 million for the first time.
